Ganirelix Acetate Patent Expiration
Ganirelix Acetate is Used for preventing premature LH surges in women undergoing controlled ovarian hyperstimulation with FSH. It was first introduced by Organon Usa Llc A Sub Of Organon And Co
Ganirelix Acetate Patents
Given below is the list of patents protecting Ganirelix Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ganirelix Acetate | US6653286 | Gonadotropin releasing hormone antagonist |
Jun 16, 2018
(Expired) | Organon Usa Organon |
| Ganirelix Acetate | US5767082 | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
Jun 16, 2015
(Expired) | Organon Usa Organon |
Ganirelix Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List